利巴韦林-话题@MedSci

#利巴韦林#

27篇内容 | 1990人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2191420, encodeId=ce272191420ae, content=<a href='/topic/show?id=0462e698012' target=_blank style='color:#2F92EE;'>#索磷布韦#</a> <a href='/topic/show?id=fb59e902862' target=_blank style='color:#2F92EE;'>#维帕他韦#</a> <a href='/topic/show?id=61073229696' target=_blank style='color:#2F92EE;'>#利巴韦林#</a> <a href='/topic/show?id=774e856e22' target=_blank style='color:#2F92EE;'>#HCV#</a> <a href='/topic/show?id=edbd88e6e7' target=_blank style='color:#2F92EE;'>#HIV#</a>, objectTitle=临床研究｜索磷布韦/维帕他韦单用或联合利巴韦林治疗3B型HCV/HIV感染者的效果及安全性, objectType=article, longId=815793, objectId=7aad815e9341, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/black-surgeon-giving-instruction-to-medical-team-TMPFGNZ.jpg, objectUrl=/article/show_article.do?id=7aad815e9341, replyNumber=0, likeNumber=81, createdTime=2024-03-06, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=7aad815e9341, moduleTitle=临床研究｜索磷布韦/维帕他韦单用或联合利巴韦林治疗3B型HCV/HIV感染者的效果及安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7aad815e9341)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=1360314, encodeId=56111360314bc, content=<a href='/topic/show?id=61073229696' target=_blank style='color:#2F92EE;'>#利巴韦林#</a>, objectTitle=GUT：索非布韦/维帕他韦联合小剂量利巴韦林是否有利于丙肝和肾功能损伤患者？, objectType=article, longId=218365, objectId=2fd3218365d6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2fd3218365d6, replyNumber=0, likeNumber=78, createdTime=2021-10-12, rootId=0, userName=meichuangyi, userId=08e4137, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2fd3218365d6, moduleTitle=GUT：索非布韦/维帕他韦联合小剂量利巴韦林是否有利于丙肝和肾功能损伤患者？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2fd3218365d6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1360313, encodeId=60f41360313be, content=<a href='/topic/show?id=61073229696' target=_blank style='color:#2F92EE;'>#利巴韦林#</a>, objectTitle=Lancet:干扰素β-1b、洛匹那韦、利托那韦和利巴韦林治疗轻中度新冠肺炎有效, objectType=article, longId=193897, objectId=c69119389efc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c69119389efc, replyNumber=0, likeNumber=93, createdTime=2020-05-12, rootId=0, userName=meichuangyi, userId=08e4137, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c69119389efc, moduleTitle=Lancet:干扰素β-1b、洛匹那韦、利托那韦和利巴韦林治疗轻中度新冠肺炎有效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c69119389efc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1360312, encodeId=ad60136031213, content=<a href='/topic/show?id=61073229696' target=_blank style='color:#2F92EE;'>#利巴韦林#</a>, objectTitle=DAA治愈慢性丙型肝炎PEG-IFN联合利巴韦林抗病毒过程中并发重度自身免疫性溶血性贫血1例, objectType=article, longId=161446, objectId=d491161446de, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d491161446de, replyNumber=0, likeNumber=80, createdTime=2019-03-02, rootId=0, userName=meichuangyi, userId=08e4137, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d491161446de, moduleTitle=DAA治愈慢性丙型肝炎PEG-IFN联合利巴韦林抗病毒过程中并发重度自身免疫性溶血性贫血1例, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d491161446de)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1360311, encodeId=54081360311ba, content=<a href='/topic/show?id=61073229696' target=_blank style='color:#2F92EE;'>#利巴韦林#</a>, objectTitle=J Gastroenterology：含有或不含利巴韦林的sofosbuvir-velpatasvir在HCV感染失代偿期肝硬化患者中的疗效和安全性分析, objectType=article, longId=157446, objectId=175b15e44699, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=175b15e44699, replyNumber=0, likeNumber=57, createdTime=2019-01-08, rootId=0, userName=meichuangyi, userId=08e4137, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=175b15e44699, moduleTitle=J Gastroenterology：含有或不含利巴韦林的sofosbuvir-velpatasvir在HCV感染失代偿期肝硬化患者中的疗效和安全性分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=175b15e44699)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1360310, encodeId=c0a213603101a, content=<a href='/topic/show?id=61073229696' target=_blank style='color:#2F92EE;'>#利巴韦林#</a>, objectTitle=Gastroenterology：吉三代联合利巴韦林可提高HCV III型感染人群治愈率, objectType=article, longId=142217, objectId=3cac14221eb4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3cac14221eb4, replyNumber=0, likeNumber=82, createdTime=2018-07-04, rootId=0, userName=meichuangyi, userId=08e4137, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3cac14221eb4, moduleTitle=Gastroenterology：吉三代联合利巴韦林可提高HCV III型感染人群治愈率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3cac14221eb4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1360309, encodeId=16f4136030989, content=<a href='/topic/show?id=61073229696' target=_blank style='color:#2F92EE;'>#利巴韦林#</a>, objectTitle=Liver Int：接受DAA与利巴韦林联合治疗的HCV患者，利巴韦林剂量的调整并不影响治疗效果, objectType=article, longId=128706, objectId=c333128e0626, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c333128e0626, replyNumber=0, likeNumber=86, createdTime=2018-02-04, rootId=0, userName=meichuangyi, userId=08e4137, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c333128e0626, moduleTitle=Liver Int：接受DAA与利巴韦林联合治疗的HCV患者，利巴韦林剂量的调整并不影响治疗效果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c333128e0626)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1360308, encodeId=617a136030852, content=<a href='/topic/show?id=61073229696' target=_blank style='color:#2F92EE;'>#利巴韦林#</a>, objectTitle=Aliment Pharmacol Ther：DAA治疗的丙肝患者：利巴韦林稳态血浆水平能预测持续应答吗？, objectType=article, longId=120226, objectId=8177120226ce, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8177120226ce, replyNumber=0, likeNumber=85, createdTime=2017-11-17, rootId=0, userName=meichuangyi, userId=08e4137, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8177120226ce, moduleTitle=Aliment Pharmacol Ther：DAA治疗的丙肝患者：利巴韦林稳态血浆水平能预测持续应答吗？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8177120226ce)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1360307, encodeId=6fe1136030ef7, content=<a href='/topic/show?id=61073229696' target=_blank style='color:#2F92EE;'>#利巴韦林#</a>, objectTitle=利巴韦林，用之前一定要三思！, objectType=article, longId=118142, objectId=c89911814299, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c89911814299, replyNumber=0, likeNumber=82, createdTime=2017-11-01, rootId=0, userName=meichuangyi, userId=08e4137, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c89911814299, moduleTitle=利巴韦林，用之前一定要三思！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c89911814299)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1360306, encodeId=193613603066f, content=<a href='/topic/show?id=61073229696' target=_blank style='color:#2F92EE;'>#利巴韦林#</a>, objectTitle=Eur J Gastroenterol Hepatol：Sofosbuvir、daclatasvir联合利巴韦林治疗改善慢性丙型肝炎患者肝功能, objectType=article, longId=114804, objectId=e5ab11480454, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e5ab11480454, replyNumber=0, likeNumber=75, createdTime=2017-10-01, rootId=0, userName=meichuangyi, userId=08e4137, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e5ab11480454, moduleTitle=Eur J Gastroenterol Hepatol：Sofosbuvir、daclatasvir联合利巴韦林治疗改善慢性丙型肝炎患者肝功能, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e5ab11480454)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1360305, encodeId=56eb136030552, content=<a href='/topic/show?id=61073229696' target=_blank style='color:#2F92EE;'>#利巴韦林#</a>, objectTitle=Lancet infect dis：对于流感，奥司他韦、金刚烷胺和利巴韦林联合疗法竟不比奥司他韦单一疗法的效果好！, objectType=article, longId=113927, objectId=636511392e4b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=636511392e4b, replyNumber=0, likeNumber=83, createdTime=2017-09-25, rootId=0, userName=meichuangyi, userId=08e4137, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=636511392e4b, moduleTitle=Lancet infect dis：对于流感，奥司他韦、金刚烷胺和利巴韦林联合疗法竟不比奥司他韦单一疗法的效果好！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=636511392e4b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1360304, encodeId=2da91360304e8, content=<a href='/topic/show?id=61073229696' target=_blank style='color:#2F92EE;'>#利巴韦林#</a>, objectTitle=感冒不要再用利巴韦林，很大伤害可致癌！, objectType=article, longId=105415, objectId=254610541583, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=254610541583, replyNumber=0, likeNumber=84, createdTime=2017-07-15, rootId=0, userName=meichuangyi, userId=08e4137, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=254610541583, moduleTitle=感冒不要再用利巴韦林，很大伤害可致癌！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=254610541583)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1360303, encodeId=15a5136030336, content=<a href='/topic/show?id=61073229696' target=_blank style='color:#2F92EE;'>#利巴韦林#</a>, objectTitle=利巴韦林并非抗病毒“万能油”, objectType=article, longId=102112, objectId=03e910211203, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=03e910211203, replyNumber=0, likeNumber=66, createdTime=2017-06-17, rootId=0, userName=meichuangyi, userId=08e4137, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=03e910211203, moduleTitle=利巴韦林并非抗病毒“万能油”, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=03e910211203)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1360302, encodeId=ab8a136030243, content=<a href='/topic/show?id=61073229696' target=_blank style='color:#2F92EE;'>#利巴韦林#</a>, objectTitle=Hepatology：感染HCV 2、3型青少年中索非布韦和利巴韦林的治疗效果, objectType=article, longId=101159, objectId=0e2b101159e0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0e2b101159e0, replyNumber=0, likeNumber=95, createdTime=2017-06-10, rootId=0, userName=meichuangyi, userId=08e4137, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0e2b101159e0, moduleTitle=Hepatology：感染HCV 2、3型青少年中索非布韦和利巴韦林的治疗效果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0e2b101159e0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1360301, encodeId=da9b13603016e, content=<a href='/topic/show?id=61073229696' target=_blank style='color:#2F92EE;'>#利巴韦林#</a>, objectTitle=Hepatology：效果评估：给予DAA治疗失败的HCV患者索非布韦-维帕他韦+利巴韦林24周, objectType=article, longId=100285, objectId=5411100285ad, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5411100285ad, replyNumber=0, likeNumber=76, createdTime=2017-06-02, rootId=0, userName=meichuangyi, userId=08e4137, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5411100285ad, moduleTitle=Hepatology：效果评估：给予DAA治疗失败的HCV患者索非布韦-维帕他韦+利巴韦林24周, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5411100285ad)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1360300, encodeId=5cba136030003, content=<a href='/topic/show?id=61073229696' target=_blank style='color:#2F92EE;'>#利巴韦林#</a>, objectTitle=利巴韦林到底怎么用, objectType=article, longId=95223, objectId=2d9b952238b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2d9b952238b, replyNumber=0, likeNumber=92, createdTime=2017-04-10, rootId=0, userName=meichuangyi, userId=08e4137, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2d9b952238b, moduleTitle=利巴韦林到底怎么用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2d9b952238b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1360299, encodeId=12e91360299a3, content=<a href='/topic/show?id=61073229696' target=_blank style='color:#2F92EE;'>#利巴韦林#</a>, objectTitle=揭开利巴韦林的红盖头,看它究竟是个什么妖？, objectType=article, longId=81303, objectId=b59b8130335, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b59b8130335, replyNumber=0, likeNumber=77, createdTime=2016-10-30, rootId=0, userName=meichuangyi, userId=08e4137, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b59b8130335, moduleTitle=揭开利巴韦林的红盖头,看它究竟是个什么妖？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b59b8130335)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1360298, encodeId=e85c136029871, content=<a href='/topic/show?id=61073229696' target=_blank style='color:#2F92EE;'>#利巴韦林#</a>, objectTitle=对付手足口病感冒发热：利巴韦林是良药还是毒药, objectType=article, longId=73875, objectId=bf67e387551, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bf67e387551, replyNumber=0, likeNumber=68, createdTime=2016-07-29, rootId=0, userName=meichuangyi, userId=08e4137, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bf67e387551, moduleTitle=对付手足口病感冒发热：利巴韦林是良药还是毒药, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bf67e387551)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1360297, encodeId=83be136029e13, content=<a href='/topic/show?id=61073229696' target=_blank style='color:#2F92EE;'>#利巴韦林#</a>, objectTitle=感冒不要再用利巴韦林，很大伤害可致癌！, objectType=article, longId=71496, objectId=dbf4e14965e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=dbf4e14965e, replyNumber=0, likeNumber=82, createdTime=2016-06-25, rootId=0, userName=meichuangyi, userId=08e4137, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=dbf4e14965e, moduleTitle=感冒不要再用利巴韦林，很大伤害可致癌！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=dbf4e14965e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1360296, encodeId=a067136029662, content=<a href='/topic/show?id=61073229696' target=_blank style='color:#2F92EE;'>#利巴韦林#</a>, objectTitle=招募患者：索非布韦联合利巴韦林（±干扰素）治疗慢性丙肝的III期临床研究, objectType=article, longId=56009, objectId=dfa856009e2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=dfa856009e2, replyNumber=0, likeNumber=72, createdTime=2015-09-11, rootId=0, userName=meichuangyi, userId=08e4137, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=dfa856009e2, moduleTitle=招募患者：索非布韦联合利巴韦林（±干扰素）治疗慢性丙肝的III期临床研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=dfa856009e2)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

利巴韦林

2020-05-29

梅斯管理员 (审核中...)

前往app查看评论内容

#索磷布韦# #维帕他韦# #利巴韦林# #HCV# #HIV#

临床研究｜索磷布韦/维帕他韦单用或联合利巴韦林治疗3B型HCV/HIV感染者的效果及安全性

2024-03-06发表于上海

meichuangyi (审核中...)

前往app查看评论内容

#利巴韦林#

GUT：索非布韦/维帕他韦联合小剂量利巴韦林是否有利于丙肝和肾功能损伤患者？

2021-10-12

meichuangyi (审核中...)

前往app查看评论内容

#利巴韦林#

Lancet:干扰素β-1b、洛匹那韦、利托那韦和利巴韦林治疗轻中度新冠肺炎有效

2020-05-12

meichuangyi (审核中...)

前往app查看评论内容

#利巴韦林#

DAA治愈慢性丙型肝炎PEG-IFN联合利巴韦林抗病毒过程中并发重度自身免疫性溶血性贫血1例

2019-03-02

meichuangyi (审核中...)

前往app查看评论内容

#利巴韦林#

J Gastroenterology：含有或不含利巴韦林的sofosbuvir-velpatasvir在HCV感染失代偿期肝硬化患者中的疗效和安全性分析

2019-01-08

meichuangyi (审核中...)

前往app查看评论内容

#利巴韦林#

Gastroenterology：吉三代联合利巴韦林可提高HCV III型感染人群治愈率

2018-07-04

meichuangyi (审核中...)

前往app查看评论内容

#利巴韦林#

Liver Int：接受DAA与利巴韦林联合治疗的HCV患者，利巴韦林剂量的调整并不影响治疗效果

2018-02-04

meichuangyi (审核中...)

前往app查看评论内容

#利巴韦林#

Aliment Pharmacol Ther：DAA治疗的丙肝患者：利巴韦林稳态血浆水平能预测持续应答吗？

2017-11-17

meichuangyi (审核中...)

前往app查看评论内容

#利巴韦林#

利巴韦林，用之前一定要三思！

2017-11-01

meichuangyi (审核中...)

前往app查看评论内容

#利巴韦林#

Eur J Gastroenterol Hepatol：Sofosbuvir、daclatasvir联合利巴韦林治疗改善慢性丙型肝炎患者肝功能

2017-10-01

meichuangyi (审核中...)

前往app查看评论内容

#利巴韦林#

Lancet infect dis：对于流感，奥司他韦、金刚烷胺和利巴韦林联合疗法竟不比奥司他韦单一疗法的效果好！

2017-09-25

meichuangyi (审核中...)

前往app查看评论内容

#利巴韦林#

感冒不要再用利巴韦林，很大伤害可致癌！

2017-07-15

meichuangyi (审核中...)

前往app查看评论内容

#利巴韦林#

利巴韦林并非抗病毒“万能油”

2017-06-17

meichuangyi (审核中...)

前往app查看评论内容

#利巴韦林#

Hepatology：感染HCV 2、3型青少年中索非布韦和利巴韦林的治疗效果

2017-06-10

meichuangyi (审核中...)

前往app查看评论内容

#利巴韦林#

Hepatology：效果评估：给予DAA治疗失败的HCV患者索非布韦-维帕他韦+利巴韦林24周

2017-06-02

meichuangyi (审核中...)

前往app查看评论内容

#利巴韦林#

利巴韦林到底怎么用

2017-04-10

meichuangyi (审核中...)

前往app查看评论内容

#利巴韦林#

揭开利巴韦林的红盖头,看它究竟是个什么妖？

2016-10-30

meichuangyi (审核中...)

前往app查看评论内容

#利巴韦林#

对付手足口病感冒发热：利巴韦林是良药还是毒药

2016-07-29

meichuangyi (审核中...)

前往app查看评论内容

#利巴韦林#

感冒不要再用利巴韦林，很大伤害可致癌！

2016-06-25

meichuangyi (审核中...)

前往app查看评论内容

#利巴韦林#

招募患者：索非布韦联合利巴韦林（±干扰素）治疗慢性丙肝的III期临床研究

2015-09-11

科室
- - 订阅+
  - 更多科室
工具
服务